Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study
Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study
Objectives Osteolysis and subsequent
prosthesis loosening is the most common cause for revision following
total knee arthroplasty (TKA) or total hip arthroplasty (THA). Hormone
replacement therapy (HRT) could reduce osteolysis through its
antiresorptive effects. We studied whether HRT use is associated with
reduced revision rates in a community-based cohort of women undergoing
TKA or THA for osteoarthritis.
Methods Female participants in the General
Practice Research Database undergoing a primary TKA or THA from 1986 to
2006 were included. We excluded patients aged <40 years at the date
of primary, and those with a history of previous hip fracture or
rheumatoid arthritis. Women with at least 6 months of HRT were
identified as HRT users. We further explored the associations among HRT
use of ≥12 months, adherence (medication possession ratio) and
cumulative use and revision risk. Cox models were fitted to model
implant survival in years. Propensity score matching was used to control
for confounding.
Results We matched 2700 HRT users to 8100
non-users, observed for a median (IQR) of 3.3 (1.5–6.1) years after
TKA/THA. HR for HRT ≥6 months was 0.62 (95% CI 0.41 to 0.94), whereas HR
for ≥12 months was 0.48 (0.29 to 0.78). Higher adherence and therapy
duration were associated with further reductions in revision rates.
Preoperative HRT appeared unrelated to implant survival.
Conclusions HRT use is associated with an
almost 40% reduction in revision rates after a TKA/THA. These findings
require replication in external cohorts and experimental studies.
557-563
Prieto-Alhambra, D.
19a5643f-5969-4c0e-b6a9-863fb9e9d1c7
Javaid, M.K.
51d3310b-032e-4c15-83ac-b878bce090f3
Judge, A.
c6a83964-1d7c-4aa8-b2bf-9c264d1e487d
Maskell, J.
20c51b6e-66ca-4d3f-a463-ba5a3168aeb8
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Arden, N.K.
23af958d-835c-4d79-be54-4bbe4c68077f
5 February 2015
Prieto-Alhambra, D.
19a5643f-5969-4c0e-b6a9-863fb9e9d1c7
Javaid, M.K.
51d3310b-032e-4c15-83ac-b878bce090f3
Judge, A.
c6a83964-1d7c-4aa8-b2bf-9c264d1e487d
Maskell, J.
20c51b6e-66ca-4d3f-a463-ba5a3168aeb8
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Arden, N.K.
23af958d-835c-4d79-be54-4bbe4c68077f
Prieto-Alhambra, D., Javaid, M.K., Judge, A., Maskell, J., Cooper, C. and Arden, N.K.
(2015)
Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study.
Annals of the Rheumatic Diseases, 74 (3), .
(doi:10.1136/annrheumdis-2013-204043).
(PMID:24451241)
Abstract
Objectives Osteolysis and subsequent
prosthesis loosening is the most common cause for revision following
total knee arthroplasty (TKA) or total hip arthroplasty (THA). Hormone
replacement therapy (HRT) could reduce osteolysis through its
antiresorptive effects. We studied whether HRT use is associated with
reduced revision rates in a community-based cohort of women undergoing
TKA or THA for osteoarthritis.
Methods Female participants in the General
Practice Research Database undergoing a primary TKA or THA from 1986 to
2006 were included. We excluded patients aged <40 years at the date
of primary, and those with a history of previous hip fracture or
rheumatoid arthritis. Women with at least 6 months of HRT were
identified as HRT users. We further explored the associations among HRT
use of ≥12 months, adherence (medication possession ratio) and
cumulative use and revision risk. Cox models were fitted to model
implant survival in years. Propensity score matching was used to control
for confounding.
Results We matched 2700 HRT users to 8100
non-users, observed for a median (IQR) of 3.3 (1.5–6.1) years after
TKA/THA. HR for HRT ≥6 months was 0.62 (95% CI 0.41 to 0.94), whereas HR
for ≥12 months was 0.48 (0.29 to 0.78). Higher adherence and therapy
duration were associated with further reductions in revision rates.
Preoperative HRT appeared unrelated to implant survival.
Conclusions HRT use is associated with an
almost 40% reduction in revision rates after a TKA/THA. These findings
require replication in external cohorts and experimental studies.
This record has no associated files available for download.
More information
Accepted/In Press date: 24 November 2013
e-pub ahead of print date: 22 January 2014
Published date: 5 February 2015
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 375458
URI: http://eprints.soton.ac.uk/id/eprint/375458
ISSN: 0003-4967
PURE UUID: d05e0209-ee61-4955-8e42-14714d28838d
Catalogue record
Date deposited: 27 Mar 2015 11:22
Last modified: 18 Mar 2024 02:45
Export record
Altmetrics
Contributors
Author:
D. Prieto-Alhambra
Author:
M.K. Javaid
Author:
A. Judge
Author:
J. Maskell
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics